基础医学与临床 ›› 2017, Vol. 37 ›› Issue (2): 156-161.

• 研究论文 • 上一篇    下一篇

腹泻型肠易激综合征患者血清抗肠神经元抗体免疫反应特点及其临床意义

陈玲玲1,2,文平2,费贵军2,王承党1,辛海威3,朱丽明2,方秀才2   

  1. 1. 福建医科大学附属第一医院消化内科 福建医科大学消化系病研究室
    2. 中国医学科学院 北京协和医学院 北京协和医院
    3. 北京协和医院
  • 收稿日期:2016-02-18 修回日期:2016-07-11 出版日期:2017-02-05 发布日期:2017-01-16
  • 通讯作者: 方秀才 E-mail:fangxiucai2@aliyun.com
  • 基金资助:
    国家国际科技合作专项项目课题;国家自然科学基金

Characteristics and clinical significance of sera anti-enteric neuronal antibodies in patients with irritable bowel syndrome with diarrhea

  • Received:2016-02-18 Revised:2016-07-11 Online:2017-02-05 Published:2017-01-16
  • Contact: Xiucai FANG E-mail:fangxiucai2@aliyun.com
  • Supported by:
    Program of international S & T cooperation

摘要: 目的 通过检测腹泻型肠易激综合征(IBS-D)患者血清中抗肠神经元抗体(AENA),分析与症状的相关性,探讨AENA在IBS发病中的可能作用。方法 纳入符合罗马Ⅲ诊断标准IBS-D患者和健康对照者,采集血清,以豚鼠黏膜下神经丛为底物,间接免疫荧光法检测血清AENA,盲法判断免疫反应染色结果;比较AENA阳性和阴性/弱阳性IBS-D患者临床症状的差别。结果 1)127例IBS-D患者AENA阳性率为85.8%;86名健康对照者阳性率为7.0%。109例AENA阳性的IBS-D患者血清分别为强阳性23.6%、阳性43.3%、弱阳性18.9%,表现为单纯胞浆染色、单纯胞核染色、胞浆和胞核染色、核膜染色、胞浆和核膜染色;6名AENA阳性的健康对照血清均为单纯胞浆染色。2)AENA强阳性的IBS-D患者,其肠道症状重于抗体阴性和弱阳性患者,表现为肠道症状计分高分(>10分者,58.8%比38.1%)、平素腹痛频发(91.7% 比60.0%)、排便前腹痛/腹部不适严重的患者比例数高(24.7%比9.5%);AENA阳性IBS-D患者排便急迫感更常见(87.3%比57.1%)。结论 AENA在IBS发病中可能起一定作用,其有望成为IBS生物学标志。

关键词: 肠易激综合征, 抗肠神经元抗体, 肠神经系统, 生物学标志物

Abstract: Objective To detect the sera anti-enteric neuronal antibodies (AENA) in irritable bowel syndrome with diarrhea (IBS-D) patients and analyzed its correlation with IBS-D symptoms to explore the potential roles of AENA in the pathogenesis of IBS. Methods IBS-D patients met the Rome III diagnostic criteria were enrolled in this study. The sera of healthy subjects were used as controls. Indirect immunofluorescence (IIF) was used to detect the sera AENA with the substrate of ileal submucosal plexus of guinea pig. The immune reactivity (IR) stains were read in blinded method. The bowel symptoms of patients with positive AENA were compared to that with negative and weekly positive antibodies. Results 1) A total of 127 IBS-D patients were enrolled in this study. The positive rate of sera AENA was 85.8% in IBS-D patients, and 7.0% in healthy controls. Among 109 IBS-D patients with positive IIF reactivity, 23.6% present with strong positive, 43.3% with positive and 18.9% with weakly positive stain. The IR patterns include cytoplasm staining, nucleus staining, cytoplasms and nuclei staining , nuclear membrane staining, cytoplasm and nuclear membrane staining. Six positive sera of healthy control showed cytoplasm staining to substrate neurons. 2) More patients of IBS-D with positive IR have higher intestinal symptoms scores (>10 scores, 58.8% vs 38.1%), frequent abdominal pain in non-defecation period (91.7% vs 60.0%), and severe abdominal pain/discomfort before defecation (24.7% vs 9.5%) comparing to those with negative and weekly positive IR of AENA; IBS-D patients with positive IR of AENA are more commonly associated with urgency comparing to those with negative IR in IIF (57.1% vs 87.3). Conclusions The results indicate AENA might play a role in the pathogenesis of IBS, and is expected to become the biomarker of IBS.

Key words: irritable bowel syndrome, anti-enteric neuronal antibodies, enteric nervous system, biomarker

中图分类号: